IRCCS Azienda Ospedaliero-Universitaria di Bologna
R&D Institution
Bologna, ItalyAbout
The IRCCS Azienda Ospedaliero-Universitaria di Bologna(IRCCS AOUBO) is Bologna's first hospital, with over 400 years of history. It is a research hospital and the main official venue of the School of Medicine and Surgery of the University of Bologna being the University's reference center for healthcare activities crucial for academic education and clinical research.
Healthcare and research activities are carried out and developed through 13 Departments of Integrated Activities (DAI) and a transversal organisation of pathways of care and homogeneous activities aimed at strengthening and improving all the distinctive activities of the hospital. IRCCS AOUBO ranks 5th among the best Italian hospitals in the"Best Hospital 2024"ranking, published by the American magazine "Newsweek", and the 66th in the global ranking. IRCCS AOUBO is an excellence research centre dedicated to translational research with the aim of improving patient care pathways and clinical practices. In 2020, the hospital was awarded the status of IRCCS - "IRCCS - Istituto di Ricovero e Cura a Carattere Scientifico - Scientific Institute for Research, Hospitalization and Healthcare” by the Italian Ministry of Health, as the result of high specialization and excellence in care and biomedical research focusing on two specific areas: 1- Assistance and research in transplantation and the critical patient 2- Integrated medical and surgical management for the treatment of oncological diseases.
The research activities addressing the two specific areas are declined ineight research lines. In addition to the two main areas, IRCCS AOUBO's ischaracterized by multi-specialistic research activities also coveringpreclinical research, which is carried out in dedicated research platforms and laboratories, and clinical research, including all phases oftranslational research(clinical trials from T1 to T4). IRCCS AOUBO hosts more than 60 disease registries and a large number ofdatasets for observational and clinical studies and is member of 12 European Reference Networks (ERNs) focusing on rare diseases and conditions that require highly specialised treatment and concentrated knowledge and resources.
Representatives
Project Manager
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Project Manager
IRCCS Azienda Ospedaliero-Universitaria di Bologna